PAR 0.00% 29.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Receives $7.36m R&D Tax Incentive Refund, page-19

  1. 7,515 Posts.
    lightbulb Created with Sketch. 6768
    Yeah, apologies, I think we are at crossed wires in saying the same thing, i.e. the January expenditure indicated by today's report not quite as surprising some seem to think above.

    The $6M indicated January spend from the reported balance in fact in keeping or even perhaps less (given higher initial outlay expenses reported) than the $8 - $11M (including R&D refund) qtrly spend guidance (i.e. $15.5 - 18.5M spend guidance excluding refund).

    Perhaps explaining the (relief?) rally today - PAR having blown out on previous guidance.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
0.000(0.00%)
Mkt cap ! $103.1M
Open High Low Value Volume
29.0¢ 29.5¢ 28.5¢ $10.95K 37.65K

Buyers (Bids)

No. Vol. Price($)
3 18687 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 85552 3
View Market Depth
Last trade - 10.56am 09/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.